Lobbying client
OCTAPHARMA USA, INC.
Sales and promotion of plasma derived products.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.
Filings
12
Filed by
3
Reported in-house
—
Reported by firms
$430,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2007 to 2026
Filings
12 filings, newest first.
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | 5 | $410,000 |
| WASHINGTON STRATEGIC CONSULTING | 1 | $20,000 |
| HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) | 3 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 7 |
| Manufacturing | MAN | 6 |
| Trade (domestic/foreign) | TRD | 5 |
| Defense | DEF | 2 |
| Budget/Appropriations | BUD | 1 |
| Health Issues | HCR | 1 |
| Pharmacy | PHA | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.